OpenAlex
PricingAboutJobs
Log inGet started
Work

GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab

HTML

Year: 2013
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-12-0989
Authors: Christian A. Gerdes, Valeria Gonzalez Nicolini, Sylvia Herter, Erwin van Puijenbroek, Sabine Lang, Michaela Roemmele, Ekkehard Moessner, Olivier Freytag, Thomas Friess, Carola H. Ries, Birgit Bossenmaier, Hans Joachim Mueller, Pablo Umaña
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: anti-EGFR monoclonal antibody, humanized monoclonal antibody, glycoengineering, FcγRIIIa binding, antibody-dependent cellular cytotoxicity, cetuximab, KRAS mutation, xenograft mouse model
SDG: Good health and well-being

Open Access status: closed

Funder: Roche Innovation Center Zurich
OpenAlex ID: W2050400262
FWCI: 6.901
Cites: 51
Cited by: 133
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security